AnnouncedFiled 23 July 2026
Allotera Therapeutics, Inc. has sold $123M so far
Allotera Therapeutics, Inc., a health care company based in St. Louis, MO, has sold $123M so far in its equity round, according to a filing dated 23 July 2026.
Announced on 27 August 2025, 330 days before the filing. wugen.com ↗
- Filed
- 23 July 2026
- First filed
- 8 September 2025
- Round
- Equity round (amended filing)
- Amount sold
- $123M
- Offering size
- $163M
- Investors so far
- 20
- Based in
- St. Louis, MO
- Industry
- Health care
- Website
- alloteratx.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 93% of the 845 tracked raises with an amount filed in 2026, and than 99% of the 72 in health care.
Allotera Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 23 Jul 2026 | Amended filing | $123M | This raise |
| 8 Sep 2025 | New filing | $109M | This raise |
| 23 Jul 2021 | New filing | $98.5M | Another raise |
| 23 Jul 2021 | New filing | $37.2M | Another raise |
More with 3x5 RiverVest on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.